Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firm
By Krishna N. Das
NEW DELHI (Reuters) – A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country’s immunisation campaign, cyber intelligence firm Cyfirma told Reuters.
Rivals China and India have both sold or gifted COVID-19 shots to many countries. India produces more than 60% of all vaccines sold in the world.
Goldman Sachs-backed Cyfirma, based in Singapore and Tokyo, said Chinese hacking group APT10, also known as Stone Panda, had identified gaps and vulnerabilities in the IT infrastructure and supply chain software of Bharat Biotech and the Serum Institute of India (SII), the world’s largest vaccine maker.
“The real motivation here is actually exfiltrating intellectual property and getting competitive advantage over Indian pharmaceutical companies,” said Cyfirma Chief Executive Kumar Ritesh, formerly a top cyber official with British foreign intelligence agency MI6.
He said APT10 was actively targeting SII, which is making the AstraZeneca vaccine for many countries and will soon start bulk-manufacturing Novavax shots.
“In the case of Serum Institute, they have found a number of their public servers running weak web servers, these are vulnerable web servers,” Ritesh said, referring to the hackers.
“They have spoken about weak web application, they are also talking about weak content-management system. It’s quite alarming.”
China’s foreign ministry did not reply to a request for comment. But responding to a question on whether Chinese hackers had a role in attacking India’s power grid which caused a blackout in Mumbai last year, the ministry said it was a staunch defender of cyber security.
“China firmly opposes and cracks down on all forms of cyber attacks,” its embassy in New Delhi said on Twitter, quoting the foreign ministry. “Speculation and fabrication have no role to play on the issue of cyber attacks.”
SII and Bharat Biotech declined to comment. The office of the director-general of the state-run Indian Computer Emergency Response Team (CERT) said the matter had been handed to its operations director, S.S. Sarma.
Sarma told Reuters CERT was a “legal agency and we can’t confirm this thing to media”.
Cyfirma said in a statement it had informed CERT authorities and that they had acknowledged the threat.
The U.S. Department of Justice said https://www.justice.gov/opa/pr/two-chinese-hackers-associated-ministry-state-security-charged-global-computer-intrusion in 2018 that APT10 had acted in association with the Chinese Ministry of State Security.
Microsoft said https://blogs.microsoft.com/on-the-issues/2020/11/13/health-care-cyberattacks-covid-19-paris-peace-forum in November that it had detected cyber attacks from Russia and North Korea targeting vaccine companies in India, Canada, France, South Korea and the United States. North Korean hackers also tried to break into the systems of British drugmaker AstraZeneca, Reuters https://www.reuters.com/article/us-healthcare-coronavirus-astrazeneca-no-idUSKBN2871A2 has reported.
Ritesh, whose firm follows the activities of some 750 cyber criminals and monitors nearly 2,000 hacking campaigns using a tool called DeCYFIR, said it was not yet clear what information APT10 may have accessed from the Indian companies.
Relations between nuclear-armed neighbours China and India soured last June when 20 Indian and four Chinese soldiers were killed in a Himalayan border fight. Recent talks have eased tension.
(Reporting by Krishna N. Das; Additional reporting by C.K. Nayak; Editing by Nick Macfie)